• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: MS

New FDA warning for Tysabri

April 28, 2010  

Chronic cerebrospinal venous insufficiency (CCSVI)

February 16, 2010  

Assessing the nocebo effect in MS trials

January 5, 2010  

Pulsed methylprednisolone: MECOMBIN trial results

January 5, 2010  

Teriflunomide in combination with beta-IFN: preliminary results

January 5, 2010  

Cognitive impairment in adolescent MS: follow-up results

December 15, 2009  

Alemtuzumab in MS: 4-year follow-up

December 15, 2009  

Vitamin D in MS: update on new studies

December 15, 2009  

EBV: an association with MS?

November 3, 2009  

Smoking may increase risk of MS disease progression

October 20, 2009  
Previous
37
38
39
40
41
Next

Browse by Topic

  • MS (414)
  • CLINICAL CASES IN MS (16)
  • EPILEPSY (36)
  • BIOMARKERS IN MS (54)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • Library (17)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • DMT prescribing in Canada – survey results posted on June 6, 2025
  • CLINICAL CASES IN MS: A 42 Y.O. WOMAN WITH A SEVERE RELAPSE ON DMF posted on June 2, 2025
  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
Copyright 2025 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions